A profiling study in GBM found a subset of neurodevelopmental TFs (including OLIG2 and SOX2) are sufficient to reprogram differentiated human GBM cells into GSCs, suggesting that OLIG2 has an important role in maintaining GSC stemness (Suva et al., 2014). The gene discussed is SOX2; the disease is glioblastoma.